Arizona Bioscience News: Innovation Challenge winners; ASU, Theranos open lab site; Mayo, TGen launch trial

July 9, 2015

By Amy Pitney

bio5_logoAlzheimer’s spurs the fearful to change their lives to delay it / Washington Post

Eric Reiman, executive director of the Banner Alzheimer’s Institute in Phoenix, discusses studies that have pointed to possible, if not fully proven, measures that may at least postpone the appearance of symptoms of Alzheimer’s disease.

6 Arizona startups get $250,000 each / Arizona Republic

Two bioscience companies are among six Arizona startups awarded $250,000 each in grant funding in the Spring 2015 Arizona Innovation Challenge, the biannual business-plan competition sponsored by the Arizona Commerce Authority.

TGen finds gene mutation responsible for syndrome / Arizona Republic (Op-ed)

The gene mutation associated with Aicardi syndrome’s discovery is a revolutionary finding with many implications about how children with the neurological disorder might be treated.

ASU, Theranos team on downtown Phoenix lab testing site, open to public / Phoenix Business Journal

Theranos Inc., which has lab-test sites in 40 Walgreens in Arizona, has partnered with Arizona State University to offer blood testing and other diagnostic services in downtown Phoenix. Read also: Do-it-yourself lab testing without doc’s orders begins

Tucson diagnostics startup wins Euro mark / Arizona Daily Star

Tucson-based Accelerate Diagnostics Inc. says it has received a key European product designation and has begun enrolling sites for a preclinical study of its system to rapidly identify bacterial infections. Read also: Accelerate leases more county space for expansion

Health Care of the Future: New twists on modern medicine / Phoenix Business Journal

Local inventors are working on technologies to solve health problems and potentially cure diseases by developing new medical devices and trying to put Arizona solidly on the map as a bioscience hub.

Arizona SciTech Festival drew 380,000 to STEM-related events / Phoenix Business Journal

The 2015 Arizona SciTech Festival drew more than 380,000 people to more than 800 events showcasing science, technology, engineering, arts and math around the state in February and March.

University of Arizona to expand on Phoenix Biomedical Campus / Phoenix Business Journal

The University of Arizona and Banner Health plan to build a 60,000-square-foot outpatient primary-care clinic on the Phoenix Biomedical Campus in downtown Phoenix.

Mayo, TGen launch clinical trial for advanced melanoma skin cancer / Phoenix Business Journal

Mayo Clinic and the Translational Genomics Research Institute are launching a national clinical trial using precision medicine to treat advanced melanoma skin cancer.

Paradigm, Cure Forward partner on NGS-based cancer molecular profiling / Genome Web

Paradigm, a spinoff of Phoenix-based International Genomics Consortium, and newly formed Cure Forward announced an agreement under which Paradigm will provide next-generation sequencing-based molecular profiling for cancer patients.

Could Amish Farm Dust Provide Relief from Asthma? / Arizona Public Media

In the first of its kind asthma study with the Amish, scientists from the University of Arizona BIO5 Institute will study dust from Amish homes and stables in Indiana to try to find a substance or substances that can prevent asthma or allergies.

Subscribe here to have Arizona Bioscience News sent directly to your inbox.